The report " Global Parenteral Nutrition Market, By Nutrition Type (Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast Till 2029’’
Key Highlights:
• In September 2019, EFCNI proudly announces the launch of their position paper “Addressing the nutritional emergency of preterm birth – Optimal practice in neonatal parenteral nutrition”.
• In August 2019, JW Life Science said that Baxter Pharmaceutical, its European partner, has launched Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN), in EU. Finomel is a third-generation nutrient solution that ideally combines omega-3 and omega-6, which promote patient recovery, and vitamin E, thus improving immunity. The product also contains the highest omega-3 content among the three-chamber PN products currently sold in the market.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Parent...
Key Market Insights from the report:
The Global Parenteral Nutrition Market accounted for US$ 5.90 billion in 2020 and is estimated to be US$ 10.33 million by 2030 and is anticipated to register a CAGR of 5.8%. The Global Parenteral Nutrition Market is segmented based on the nutrition type and region.
• By Nutrition Type, the market is segmented into Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals.
• By Region, the Global Parenteral Nutrition Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global parenteral nutrition market.
Competitive Landscape:
The key players operating in the global Parenteral Nutrition Market includes Actavis, Inc., Aculife, Healthcare Private Ltd. , Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Grifols International S.A., Otsuka Pharmaceutical Factory, Inc., Sichuan Kelun Pharmaceutical Co. Ltd. and Vifor Pharma.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
• Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]